Ropivacaine Hydrochloride
- Product NDC
- 67457-876
- 11-digit product format
- 674570876
- Labeler code
- 67457
- Product ID
- 67457-876_7006cce5-a917-4f4d-9620-1933ef256a87
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ropivacaine hydrochloride
- Dosage form
- INJECTION, SOLUTION
- Route
- EPIDURAL; INFILTRATION; PERINEURAL
- Labeler
- Mylan Institutional LLC
- Application
- ANDA090318
- Marketing category
- ANDA
- Marketing start
- 2019-05-23
- Marketing end
- 2021-03-31
- Substance
- ROPIVACAINE HYDROCHLORIDE
- Active strength
- 150 mg/30mL
- Pharmacologic classes
- Amide Local Anesthetic [EPC],Amides [CS],Local Anesthesia [PE]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 67457-876-30 | 67457087630 | 1 VIAL in 1 CARTON (67457-876-30) > 30 mL in 1 VIAL | 1 vial | 2019-05-23 | 2021-03-31 | No | No | Current |
| 67457-876-99 | 67457087699 | 5 VIAL in 1 CARTON (67457-876-99) > 30 mL in 1 VIAL | 5 vial | 2019-05-23 | 2021-03-31 | No | No | Current |